{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T18:26:38Z","timestamp":1776882398654,"version":"3.51.2"},"reference-count":124,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007253","name":"Nancy Taylor Foundation for Chronic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Thorek Memorial Foundation"},{"name":"Allen Distinguished Investigator Program"},{"name":"The Paul G. Allen Frontiers Group","award":["AR061042"],"award-info":[{"award-number":["AR061042"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["AG46927"],"award-info":[{"award-number":["AG46927"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["AR48852"],"award-info":[{"award-number":["AR48852"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["AG15768"],"award-info":[{"award-number":["AG15768"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["AR48182"],"award-info":[{"award-number":["AR48182"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["AR067467"],"award-info":[{"award-number":["AR067467"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["AR065956"],"award-info":[{"award-number":["AR065956"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["OD008586"],"award-info":[{"award-number":["OD008586"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["GM119914"],"award-info":[{"award-number":["GM119914"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["HG007900"],"award-info":[{"award-number":["HG007900"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["DA036865"],"award-info":[{"award-number":["DA036865"]}]},{"name":"The Paul G. Allen Frontiers Group","award":["AR069085"],"award-info":[{"award-number":["AR069085"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.molmed.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T13:00:29Z","timestamp":1504616429000},"page":"917-931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Genome Engineering for Personalized Arthritis Therapeutics"],"prefix":"10.1016","volume":"23","author":[{"given":"Shaunak S.","family":"Adkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Brunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent P.","family":"Willard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Lung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Gersbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshid","family":"Guilak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2017.08.002_bib0005","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2017.08.002_bib0010","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1038\/nrdp.2016.72","article-title":"Osteoarthritis","volume":"2","author":"Martel-Pelletier","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.molmed.2017.08.002_bib0015","first-page":"1531","article-title":"Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis","volume":"29","author":"Huemer","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0020","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00508-016-1111-9","article-title":"An overview of psoriatic arthritis \u2014 epidemiology, clinical features, pathophysiology and novel treatment targets","volume":"128","author":"Kerschbaumer","year":"2016","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.molmed.2017.08.002_bib0025","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.08.002_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cger.2010.03.002","article-title":"Age-related changes in the musculoskeletal system and the development of osteoarthritis","volume":"26","author":"Loeser","year":"2010","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.molmed.2017.08.002_bib0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrrheum.2017.50","article-title":"The role of metabolism in the pathogenesis of osteoarthritis","volume":"13","author":"Mobasheri","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0040","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1136\/annrheumdis-2014-205601","article-title":"Dietary fatty acid content regulates wound repair and the pathogenesis of osteoarthritis following joint injury","volume":"74","author":"Wu","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2017.08.002_bib0045","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","article-title":"American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis","volume":"68","author":"Singh","year":"2015","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0060","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/annrheumdis-2014-207080","article-title":"Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms","volume":"75","author":"Ajeganova","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2017.08.002_bib0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/annrheumdis-2016-210713","article-title":"Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"76","author":"Nam","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2017.08.002_bib0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.11481","article-title":"Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission","volume":"50","author":"Molenaar","year":"2004","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0075","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1002\/art.23945","article-title":"An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis","volume":"58","author":"Brown","year":"2008","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrrheum.2013.8","article-title":"The problem of choice: current biologic agents and future prospects in RA","volume":"9","author":"Choy","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0085","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.mayocp.2012.04.011","article-title":"Vasculitis associated with tumor necrosis factor-\u03b1 inhibitors","volume":"87","author":"Sokumbi","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.molmed.2017.08.002_bib0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0100","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/ar4591","article-title":"Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis","volume":"16","author":"Furman","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molmed.2017.08.002_bib0105","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2","article-title":"Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist","volume":"41","author":"Bresnihan","year":"1998","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.semarthrit.2016.09.003","article-title":"Defining the optimal biological monotherapy in rheumatoid arthritis: a systematic review and meta-analysis of randomised trials","volume":"46","author":"Tarp","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.molmed.2017.08.002_bib0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","article-title":"American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee","volume":"64","author":"Hochberg","year":"2012","journal-title":"Arthrit. Rheum. Arthr."},{"key":"10.1016\/j.molmed.2017.08.002_bib0120","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.2017.5283","article-title":"Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial","volume":"317","author":"McAlindon","year":"2017","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.molmed.2017.08.002_bib0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1373\/clinchem.2011.181073","article-title":"Personalized cancer genomics: the road map to clinical implementation","volume":"58","author":"Yousef","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molmed.2017.08.002_bib0130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5435\/JAAOS-20-08-536","article-title":"Orthogenomics: an update","volume":"20","author":"Matzko","year":"2012","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"10.1016\/j.molmed.2017.08.002_bib0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR technologies in research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0140","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","article-title":"Genome editing with engineered zinc finger nucleases","volume":"11","author":"Urnov","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2017.08.002_bib0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/ng.2232","article-title":"Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis","volume":"44","author":"Stahl","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2017.08.002_bib0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/ard.2010.141473","article-title":"Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study","volume":"70","author":"Panoutsopoulou","year":"2011","journal-title":"Ann. Rheum."},{"key":"10.1016\/j.molmed.2017.08.002_bib0155","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.1402238","article-title":"Positional identification of RT1-B (HLA-DQ) as susceptibility locus for autoimmune arthritis","volume":"194","author":"Haag","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/368639a0","article-title":"Limb alterations in brachypodism mice due to mutations in a new member of the TGF\u03b2-superfamily","volume":"368","author":"Storm","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.08.002_bib0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/2005","article-title":"A functional polymorphism in the 5\u2032 UTR of GDF5 is associated with susceptibility to osteoarthritis","volume":"39","author":"Miyamoto","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2017.08.002_bib0170","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1093\/hmg\/ddm174","article-title":"An SNP in the 5\u2032-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage","volume":"16","author":"Southam","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.08.002_bib0175","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/hmg\/ddn038","article-title":"A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5\u2032 UTR of GDF5 with osteoarthritis susceptibility","volume":"17","author":"Chapman","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2017.08.002_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-15-404","article-title":"Association between GDF5 rs143383 polymorphism and knee osteoarthritis: an updated meta-analysis based on 23,995 subjects","volume":"15","author":"Pan","year":"2014","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.molmed.2017.08.002_bib0185","doi-asserted-by":"crossref","first-page":"20784","DOI":"10.18632\/oncotarget.15265","article-title":"Three single nucleotide polymorphisms of TNFAIP3 gene increase the risk of rheumatoid arthritis","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.molmed.2017.08.002_bib0190","doi-asserted-by":"crossref","first-page":"e0131960","DOI":"10.1371\/journal.pone.0131960","article-title":"Genetic case-control study for eight polymorphisms associated with rheumatoid arthritis","volume":"10","author":"Saad","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2017.08.002_bib0195","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1371\/journal.pmed.0040278","article-title":"A candidate gene approach identifies the TRAF1\/C5 region as a risk factor for rheumatoid arthritis","volume":"4","author":"Kurreeman","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.molmed.2017.08.002_bib0200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2017.08.002_bib0205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60681-3","article-title":"Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study","volume":"380","author":"arcOGEN Consortium","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2017.08.002_bib0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gene.2016.04.019","article-title":"Expression of nucleostemin gene in primary osteoarthritis","volume":"587","author":"Louka","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.molmed.2017.08.002_bib0215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.08.002_bib0220","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/annrheumdis-2016-210025","article-title":"Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases","volume":"76","author":"Hinks","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2017.08.002_bib0225","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.27688","article-title":"The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1","volume":"62","author":"Thompson","year":"2010","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0230","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/art.27424","article-title":"Juvenile idiopathic arthritis and HLA Class I and Class II interactions and age-at-onset effects","volume":"62","author":"Hollenbach","year":"2010","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0235","first-page":"130","article-title":"DNA double strand break repair via non-homologous end-joining","volume":"2","author":"Davis","year":"2013","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nbt.3481","article-title":"Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA","volume":"34","author":"Richardson","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0245","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nmeth.3630","article-title":"Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements","volume":"12","author":"Thakore","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2017.08.002_bib0250","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1073\/pnas.95.25.14628","article-title":"Toward controlling gene expression at will: specific regulation of the erbB-2\/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks","volume":"95","author":"Beerli","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nmeth.3733","article-title":"Editing the epigenome: technologies for programmable transcription and epigenetic modulation","volume":"13","author":"Thakore","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2017.08.002_bib0260","first-page":"46545","article-title":"CRISPR\u2013Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome","volume":"7","author":"Klann","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0265","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","article-title":"Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain","volume":"93","author":"Kim","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0270","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1073\/pnas.89.16.7345","article-title":"Toward rules relating zinc finger protein sequences and DNA binding site preferences","volume":"89","author":"Desjarlais","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0275","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1021\/ar500039w","article-title":"Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies","volume":"47","author":"Gersbach","year":"2014","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0280","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1073\/pnas.040552697","article-title":"Positive and negative regulation of endogenous genes by designed transcription factors","volume":"97","author":"Beerli","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0285","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/S0960-9822(02)01391-X","article-title":"Gene-specific targeting of h3k9 methylation is sufficient for initiating repression in vivo","volume":"12","author":"Snowden","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0290","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-phyto-080508-081936","article-title":"Xanthomonas AvrBs3 family-type III effectors: discovery and function","volume":"48","author":"Boch","year":"2010","journal-title":"Annu. Rev. Phytopathol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0295","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.1178811","article-title":"Breaking the code of DNA binding specificity of TAL-type III effectors","volume":"326","author":"Boch","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nbt.1755","article-title":"A TALE nuclease architecture for efficient genome editing","volume":"29","author":"Miller","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0305","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1073\/pnas.1019533108","article-title":"De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks","volume":"108","author":"Mahfouz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/nar\/gkq704","article-title":"TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain","volume":"39","author":"Li","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0315","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1093\/nar\/gks875","article-title":"Chimeric TALE recombinases with programmable DNA sequence specificity","volume":"40","author":"Mercer","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0320","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/nbt.2726","article-title":"Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins","volume":"31","author":"Maeder","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0325","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ncomms1962","article-title":"Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains","volume":"3","author":"Cong","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2017.08.002_bib0330","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nmeth.2361","article-title":"Synergistic and tunable human gene activation by combinations of synthetic transcription factors","volume":"10","author":"Perez-Pinera","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2017.08.002_bib0335","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0340","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0345","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.aad5143","article-title":"In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy","volume":"351","author":"Nelson","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0350","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0355","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.aad5725","article-title":"Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy","volume":"351","author":"Long","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nbt.3199","article-title":"Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers","volume":"33","author":"Hilton","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA methylation in the mammalian genome","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2017.08.002_bib0370","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40634-017-0077-5","article-title":"Effects of combined rAAV-mediated TGF-\u03b2 and sox9 gene transfer and overexpression on the metabolic and chondrogenic activities in human bone marrow aspirates","volume":"4","author":"Tao","year":"2017","journal-title":"J. Exp. Orthop."},{"key":"10.1016\/j.molmed.2017.08.002_bib0375","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/jor.23228","article-title":"rAAV-mediated combined gene transfer and overexpression of TGF-\u03b2 and SOX9 remodels human osteoarthritic articular cartilage","volume":"34","author":"Tao","year":"2016","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0380","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/jcb.24430","article-title":"Growth factor transgenes interactively regulate articular chondrocytes","volume":"114","author":"Shi","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2017.08.002_bib0385","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mt.2011.2","article-title":"\u2018Same day\u2019 ex-vivo regional gene therapy: a novel strategy to enhance bone repair","volume":"19","author":"Virk","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2017.08.002_bib0390","doi-asserted-by":"crossref","first-page":"E798","DOI":"10.1073\/pnas.1321744111","article-title":"Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage","volume":"111","author":"Brunger","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0395","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.biomaterials.2014.04.113","article-title":"A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP","volume":"35","author":"Gao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.molmed.2017.08.002_bib0400","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","article-title":"Genome-editing technologies for gene and cell therapy","volume":"24","author":"Maeder","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2017.08.002_bib0405","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1016\/j.biomaterials.2014.03.073","article-title":"Biomaterials","volume":"35","author":"Glass","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.molmed.2017.08.002_bib0410","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.trsl.2013.01.002","article-title":"Arthritis gene therapy and its tortuous path into the clinic","volume":"161","author":"Evans","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0415","first-page":"591","article-title":"Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis","volume":"6","author":"Kim","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2017.08.002_bib0420","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jgm.1053","article-title":"Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis","volume":"9","author":"Khoury","year":"2007","journal-title":"J. Gene Med."},{"key":"10.1016\/j.molmed.2017.08.002_bib0425","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/mt.2012.131","article-title":"IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis","volume":"21","author":"Garaulet","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2017.08.002_bib0430","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.gt.3302182","article-title":"An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint","volume":"11","author":"van de Loo","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2017.08.002_bib0435","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/art.23598","article-title":"Application of inflammation-responsive promoter for an in vitro arthritis model","volume":"58","author":"Rachakonda","year":"2008","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0440","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/nar\/gkv019","article-title":"A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells","volume":"43","author":"M\u00fcller-Kuller","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2017.08.002_bib0445","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1073\/pnas.251682798","article-title":"Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos","volume":"99","author":"Pfeifer","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0450","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nmeth.1674","article-title":"Site-specific integration and tailoring of cassette design for sustainable gene transfer","volume":"8","author":"Lombardo","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.molmed.2017.08.002_bib0455","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","article-title":"Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs","volume":"8","author":"Brunger","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2017.08.002_bib0460","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.39982","article-title":"CRISPR\/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues","volume":"69","author":"Brunger","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0465","doi-asserted-by":"crossref","DOI":"10.1089\/ten.tea.2016.0441","article-title":"CRISPR-based epigenome editing of cytokine receptors for the promotion of cell survival and tissue deposition in inflammatory environments","author":"Farhang","year":"2017","journal-title":"Tissue Eng. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0470","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.cell.2016.11.033","article-title":"Disease model of GATA4 mutation reveals transcription factor cooperativity in human cardiogenesis","volume":"167","author":"Ang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2017.08.002_bib0475","doi-asserted-by":"crossref","first-page":"19172","DOI":"10.1073\/pnas.1210422109","article-title":"Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells","volume":"109","author":"Diekman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0480","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.stem.2010.12.008","article-title":"Stage-specific optimization of activin\/nodal and bmp signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines","volume":"8","author":"Kattman","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2017.08.002_bib0485","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.5966\/sctm.2013-0128","article-title":"A site-specific integrated Col2.3GFP reporter identifies osteoblasts within mineralized tissue formed in vivo by human embryonic stem cells","volume":"3","author":"Xin","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.molmed.2017.08.002_bib0490","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.stemcr.2014.09.013","article-title":"A CRISPR\/Cas9-based system for reprogramming cell lineage specification","volume":"3","author":"Chakraborty","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2017.08.002_bib0495","first-page":"406","article-title":"Targeted epigenetic remodeling of endogenous loci by CRISPR\/Cas9-based transcriptional activators directly converts fibroblasts to neuronal cells","volume":"19","author":"Black","year":"2016","journal-title":"Stem Cell"},{"key":"10.1016\/j.molmed.2017.08.002_bib0500","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/art.38780","article-title":"Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening","volume":"66","author":"Willard","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0505","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.3210","article-title":"Generation of articular chondrocytes from human pluripotent stem cells","volume":"33","author":"Craft","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0510","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.stemcr.2015.01.016","article-title":"Generation of scaffoldless hyaline cartilaginous tissue from human iPSCs","volume":"4","author":"Yamashita","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.molmed.2017.08.002_bib0515","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1096\/fj.14-269720","article-title":"Early induction of a prechondrogenic population allows efficient generation of stable chondrocytes from human induced pluripotent stem cells","volume":"29","author":"Lee","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.molmed.2017.08.002_bib0520","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00439-014-1447-z","article-title":"CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383","volume":"133","author":"Reynard","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2017.08.002_bib0525","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14136","article-title":"Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex","volume":"517","author":"Konermann","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.08.002_bib0530","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cell.2015.06.059","article-title":"A genome-wide CRISPR screen in primary immune cells to dissect regulatory networks","volume":"162","author":"Parnas","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2017.08.002_bib0535","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.cell.2016.11.039","article-title":"Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-seq","volume":"167","author":"Jaitin","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2017.08.002_bib0540","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","article-title":"Genetic screens in human cells using the CRISPR-Cas9 system","volume":"343","author":"Wang","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0545","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0550","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aag2445","article-title":"Systematic mapping of functional enhancer\u2013promoter connections with CRISPR interference","volume":"354","author":"Fulco","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0555","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.aaf7613","article-title":"High-resolution interrogation of functional elements in the noncoding genome","volume":"353","author":"Sanjana","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0560","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nbt.3450","article-title":"Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9","volume":"34","author":"Korkmaz","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0565","article-title":"Discovery of an autoimmunity-associated IL2RA enhancer by unbiased targeting of transcriptional activation","author":"Simeonov","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.molmed.2017.08.002_bib0570","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","article-title":"Statin treatment rescues FGFR3 skeletal dysplasia phenotypes","volume":"513","author":"Yamashita","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.08.002_bib0575","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.38912","article-title":"Enhanced chondrogenesis of induced pluripotent stem cells from patients with neonatal-onset multisystem inflammatory disease occurs via the caspase 1-independent cAMP\/protein kinase A\/CREB pathway","volume":"67","author":"Yokoyama","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0580","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt.2052","article-title":"Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells","volume":"29","author":"Kim","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0585","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature22403","article-title":"Common genetic variation drives molecular heterogeneity in human iPSCs","volume":"546","author":"Kilpinen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.08.002_bib0590","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.matbio.2016.04.002","article-title":"CRISPR\/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention","volume":"56","author":"Huang","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.molmed.2017.08.002_bib0595","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bone.2014.09.005","article-title":"CRISPR\/Cas9 mediated generation of stable chondrocyte cell lines with targeted gene knockouts; analysis of an aggrecan knockout cell line","volume":"69","author":"Yang","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2017.08.002_bib0600","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T Cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2017.08.002_bib0605","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2017.08.002_bib0610","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.1254445","article-title":"Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA","volume":"345","author":"Long","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2017.08.002_bib0615","doi-asserted-by":"crossref","first-page":"E6199","DOI":"10.1073\/pnas.1608245113","article-title":"Suppression of NF-\u03baB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injury","volume":"113","author":"Yan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2017.08.002_bib0620","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrrheum.2017.6","article-title":"What rheumatologists need to know about CRISPR\/Cas9","volume":"13","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491417301429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491417301429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T03:51:04Z","timestamp":1602906664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491417301429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":124,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1471491417301429"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2017.08.002","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome Engineering for Personalized Arthritis Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}